The present invention relates to an orodispersible tablet comprised of, by weight: a maximum of 15% of a low-dose, therapeutically active substance； from 55% to 70% of mannitol of a particle size between 30 µm and 300 µm； at least 2% of maltodextrin； from 3.5% to 8% of croscarmellose sodium； from 10% to 20% of microcrystalline cellulose； from 0.5% to 1.5% of magnesium stearate； and from 1% to 5% of flavoring (s) and sweetener (s).
